BioSig Technologies, Inc. STEX Corporate — Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s corporate — operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s corporate — operating expenses?
- BioSig Technologies, Inc. (STEX) reported corporate — operating expenses of $35.75M in Q1 2026.
- How has BioSig Technologies, Inc.'s corporate — operating expenses changed year-over-year?
- BioSig Technologies, Inc.'s corporate — operating expenses increased by 1097.9% year-over-year, from $2.98M to $35.75M.
- What is the long-term trend for BioSig Technologies, Inc.'s corporate — operating expenses?
- Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s corporate — operating expenses has grown at a 24.1% compound annual growth rate (CAGR), from $30.02M to -$71.09M.
- What does corporate — operating expenses mean?
- The total costs incurred by the corporate segment to maintain day-to-day operations, excluding non-operating items. Monitoring this metric helps assess the overall cost structure and operational leverage of the business segment.